|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
9
|
Resverlogix Corp.
|
Mar 18, 2021 09:43AM
|
|
Re: Sept 30 2022 - Resverlogix streaming video
|
9
|
Resverlogix Corp.
|
Oct 03, 2022 05:24PM
|
|
Re: Shawn lu RSU and option cancelled
|
9
|
Resverlogix Corp.
|
Apr 07, 2020 03:09PM
|
|
Re: That's a Strong P Value....
|
9
|
Resverlogix Corp.
|
Feb 23, 2017 11:00AM
|
|
Re: DM conflict of interest
|
9
|
Resverlogix Corp.
|
Nov 09, 2023 03:15PM
|
|
Re: Great Discussion
|
9
|
Resverlogix Corp.
|
Oct 16, 2017 01:45PM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
9
|
Resverlogix Corp.
|
Jun 22, 2022 03:41PM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
9
|
Resverlogix Corp.
|
Dec 15, 2021 02:05PM
|
|
Some thoughts
|
9
|
Resverlogix Corp.
|
Jun 01, 2021 10:53PM
|
|
Re: And we wait.......
|
9
|
Resverlogix Corp.
|
Jan 23, 2018 10:32PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
9
|
Resverlogix Corp.
|
Apr 15, 2021 11:58AM
|
|
NKF Presentation
|
9
|
Resverlogix Corp.
|
Mar 18, 2020 09:29AM
|
|
Re: MP's and MLA's - letter
|
9
|
Resverlogix Corp.
|
May 15, 2021 11:18AM
|
|
Re: Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
9
|
Resverlogix Corp.
|
Nov 01, 2021 10:22AM
|
|
Re: Warning: Long - Thoughts on Management
|
9
|
Resverlogix Corp.
|
Mar 28, 2021 04:48PM
|
|
Re: Biotech Valuation
|
9
|
Resverlogix Corp.
|
Mar 30, 2021 04:46PM
|
|
Masila’s note to BDAZ
|
9
|
Resverlogix Corp.
|
Sep 27, 2019 10:53AM
|
|
Re: Zenith-Oncology Pipeline
|
9
|
Zenith Epigenetics
|
Mar 18, 2021 03:12PM
|
|
Re: The problem...as I see it
|
9
|
Resverlogix Corp.
|
Oct 18, 2020 10:34AM
|
|
Re: Comments on today's annual update
|
9
|
Resverlogix Corp.
|
Jun 23, 2021 08:08AM
|
